Full length articleTetramethylpyrazine (cas 1124-11-4) attenuates blood-brain barrier disruption in ischemia/reperfusion injury through the JAK/STAT signaling pathway

Add time:09/30/2019    Source:sciencedirect.com

Tetramethylpyrazine (TMP) has been studied in depth and is widely used in the treatment of many kinds of diseases in China. However, whether it has neuroprotective effects on cerebral ischemia remains unclear. An ischemia/reperfusion (I/R) injury animal model was established via middle cerebral artery occlusion in this study. We set several different groups in which the rats were performed in different ways to explore the effects of TMP on blood-brainbarrier (BBB) disruption and determine whether TMP relieved BBB disruption through blocking the JAK/STAT signaling pathway. Our results showed that TMP could reduce the neurological functional loss, decrease the brain edema and BBB permeability, as well as increase the expression of tight junction proteins via inhibiting the activation of JAK/STAT signaling pathway. Overall, we demonstrated that TMP promoted neurological recovery after I/R injury via restoring the integrity and function of BBB.

We also recommend Trading Suppliers and Manufacturers of Tetramethylpyrazine (cas 1124-11-4). Pls Click Website Link as below: cas 1124-11-4 suppliers

Prev:Tetramethylpyrazine (cas 1124-11-4) ameliorates experimental autoimmune encephalomyelitis by modulating the inflammatory response
Next:Differentiation of phenylpropanoid acids cyclobutane- and dehydrodimers isomers in barley leaf cell walls with LC/MS/MS system)